Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Thursday, April 18, 2024

Increase in Demand of Ayurveda Products During & Post COVID-19 Pandemic:...

The demand for honey has gone up by 45%, Chyawanprash by 85% and turmeric by 40% New Delhi, March 27, 2021: The onset of the COVID-19...

Biotechnology

Apex Group of Hospitals Doctors use Botox treatment to restore Mumbai Falooda Seller voice...

Mumbai, August 22, 2023:  Mumbai- 40-year-old vendor from Bhayander by profession falooda seller Nishikanat Bhagwat (name changed)  was suffering from a voice problem from...

DEP’s innovative solution MeshWorks 2020 is set to revolutionize the Bio-Medical Industry

MeshWorks 2020 will make product development in the healthcare industry more efficient and productive Chennai, May 14, 2020: DEP MeshWorks 2020, a CAE driven engineering platform, for...

IT & Software Support

Wipro GE Healthcare keen to make diagnostics affordable to all

Wipro GE Healthcare is keen to invest in technologies that are affordable to all.

Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.

INDIA MANUFACTURE

“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.

Appointments

Prashant Nagre elevated to the position of Managing Director of Fermenta Biotech Limited

Strategic decision to fuel next phase of growth for the company New Delhi, May 11, 2021: Mr Krishna Datla, Promoter and Managing Director of Fermenta...

Awards

Columbia Asia Hospital Hebbal conferred with ‘Best Green Hospital Award’ under the Social Footprint category of the Express Healthcare Excellence Awards 2019

Columbia Asia Hospital Hebbal conferred with ‘Best Green Hospital Award’ under the Social Footprint...

Bengaluru, August 09, 2019: Columbia Asia Hospital Hebbal has been honoured with the 'Best Green Hospital Award' under Social Footprint category of the Express Healthcare Excellence...

Sepsivac® receives Covid-19 Pharma Excellence Award

Ahmedabad, August 26, 2020: Sepsivac®,the latest innovation Cadila Pharmaceutical recently received the prestigious Pharma Excellence Awardat the Emerging Dimensions in Pharma Excellence e-Summit organised...

Financial Results

Approvals

Clinical Trails

Eisai Presents Latest Data of Phase I Clinical Trial on Liposomal Formulation of Anti-Cancer...

Tokyo, September 18, 2020: Eisai Co., Ltd. has announced that the latest results from the cohort targeting patients with HER2-negative breast cancer in phase...

LANXESS plans to expand capacity for Oxone monopersulfate – a main active ingredient for...

·         Production increase of around 50 percent targeted ·         Investment amount in the lower double-digit million euro range ·         Significant increase in demand due to African swine fever and...

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Importance of eye health during this lockdown and 5 ways to keep our eyes...

By Hemanth Manay, CEO & Chief Consultant Optometrist, S.R. Gopal Rao Opticians & Optometrists The current situation does not allow for us to move out...

Optimizing Optic Health: Your Comprehensive Guide to Glaucoma Mastery

Dr. K Harshitha, Cataract and Glaucoma Surgeon, Maxivision Eye Hospitals, Hyderabad Glaucoma, often known as the "silent thief of sight," is a group of eye...

Seeing the world differently :Eye Donation Fortnight By Dr. Shibu Varkey- Dr. Shibu Varkey,...

The realm of ophthalmology stands witness to remarkable advancements in medical science that have revolutionized the treatment of visual impairments. However, amidst the array...

Product News

Media Partners

Spotlight

Investments

Packaging

Latest News

Dental Care

Tips to maintain oral health!

By Dr.MS Prasad, Dental Surgeon, Columbia Asia Referral Hospital Yeshwanthpur It has been said that a person’s real happiness begins from the plate and is...

Hospital Management

Drug Discovery & Development

Drug Discovery Unit (DDU), University of Dundee Licenses GVK BIO Online SAR Database (GOSTAR)

Hyderabad, Andhra Pradesh, India, Wednesday, April 10, 2013 -- (Business Wire India) -- GVK Biosciences (GVK BIO) today announced that it has licensed its Online SAR Database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually curated database, has been developed over the span of a decade by a team comprising of more than 200 curators. The product issued globally in various areas such as pharmaceuticals, academics, government sectors, apart from numerous publications that cite the data contained in GOSTAR. GOSTAR contains over 6 million compounds manually curated through the screening of over 2 million patents and 400,000 journals and it also contains more than 18 million quantitative SAR points.

Suppliers

Technology

Companies

Marketing

Our Partners

Machinery & Equipments